SCHEMBL5657669

SCHEMBL5657669

COc1cccc(N2C(=O)C(c3cc(C)c(O)c(C)c3)(c3ccc(C)c(C)c3O)c3ccccc32)c1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.39
ALDH1A1 P00352 6/20 0.38
KDM4E B2RXH2 2/20 0.38
MGLL Q99685 1/20 0.38
SCN9A Q15858 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
POLB P06746 1/20 0.35
RECQL P46063 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP1A2 P05177 1/20 0.34
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
ALOX15 P16050 1/20 0.34
HPGD P15428 1/20 0.34
TP53 P04637 1/20 0.34
GAA P10253 1/20 0.33
GFER P55789 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5658788 0.93 MAPT (0.38) MAPTALDH1A1KDM4EMGLLSCN9A
SCHEMBL5656443 0.91 MAPT (0.44) MAPTALDH1A1KDM4EMGLLSCN9A
SCHEMBL5662112 0.90 MAPT (0.41) MAPTALDH1A1KDM4EMGLLSCN9A
SCHEMBL5659702 0.89 NPSR1 (0.37) MAPTALDH1A1KDM4EMGLLPOLB
SCHEMBL5656731 0.89 MAPT (0.41) MAPTALDH1A1KDM4EMGLLSCN9A
SCHEMBL5661921 0.89 MAPT (0.41) MAPTALDH1A1KDM4EMGLLSCN9A
SCHEMBL5659844 0.89 OPRL1 (0.33) POLBRECQLNPSR1TDP1
SCHEMBL14457633 0.87 MAPT (0.40) MAPTALDH1A1KDM4EMGLLSCN9A
SCHEMBL5661620 0.87 MAPT (0.38) MAPTALDH1A1KDM4EMGLLSCN9A
SCHEMBL5658260 0.87 ALDH1A1 (0.40) MAPTALDH1A1KDM4EMGLLSCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators NR3C2, NR5A1, NR5A2 MAPT 3588/4885ALDH1A1 723/4885KDM4E 4466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.